News Interim report for 1H 2023 Please read the full announcement in PDF Attachment 2023_54_Q22023_CompanyAnnouncement Continue Reading Previous Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticariaNext Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook Related Stories News Gaming Industry Veteran Kent Young Launches New AI-Powered Gaming Technology and Content Venture, Predigy News Gaming Industry Veteran Kent Young Launches New AI-Powered Gaming Technology and Content Venture, Predigy News LPKWJ DIGITAL SERVICES LTDA Expands Technology Investment News LPKWJ DIGITAL SERVICES LTDA Expands Technology Investment News GA-ASI Makes Another Autonomous Aerial Intercept in Company-Funded Demo with MQ-20 Avenger(R) News Asian Financial Forum opens next Monday as the region’s first major international financial event of 2026
